Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Antitubercular agent-38

Antitubercular agent-38 is an orally active Benzothiazinones (BTZs) derivate, with potent antituberculosis activity. Antitubercular agent-38 exhibits low cardiac toxicity, low cell cytotoxicity[1].

Product Specifications

CAS Number

9007-83-4

UNSPSC

12352005

Target

Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/antitubercular-agent-38.html

Solubility

10 mM in DMSO

Smiles

FC(F)(F)C1=CC([N+]([O-])=O)=C2C(C(N=C(N3CCN(N(C4CCC(C)(C)CC4)C)CC3)S2)=O)=C1

Molecular Formula

C22H28F3N5O3S

Molecular Weight

499.55

References & Citations

[1]Wang A, et al. Design, synthesis and antitubercular activity of novel N- (amino) piperazinyl benzothiazinones with improved safety. Eur J Med Chem. 2023 Oct 5;258:115545.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

More Discoveries

Explore Other Products

Browse additional items from our catalog

PPHLN1 CytoSection
TS422352P5 25 Slides

PPHLN1 CytoSection

Sign In for Pricing
View Details
Pop5 (NM_026398) Mouse Recombinant Protein
E45M48651M5 20 µg

Pop5 (NM_026398) Mouse Recombinant Protein

Sign In for Pricing
View Details
4-Bromo-2-{[ (tert-butyldimethylsilyl) oxy]methyl}aniline
PYB24837-01 250 mg

4-Bromo-2-{[ (tert-butyldimethylsilyl) oxy]methyl}aniline

Sign In for Pricing
View Details
4-Bromo-2-{[ (tert-butyldimethylsilyl) oxy]methyl}aniline
PYB24837-02 2.5 g

4-Bromo-2-{[ (tert-butyldimethylsilyl) oxy]methyl}aniline

Sign In for Pricing
View Details
CCAR2 Monoclonal Antibody
A10417-100UL 100 µL

CCAR2 Monoclonal Antibody

Sign In for Pricing
View Details
SLFN12 antibody - N-terminal region (ARP57095_P050)
ARP57095_P050 100 µL

SLFN12 antibody - N-terminal region (ARP57095_P050)

Sign In for Pricing
View Details